Merck touts a 60% price cut, but the drug is outdated and on the way out

Merck touts a 60% price cut, but the drug is outdated and on the way out

Source: 
Marketwatch
snippet: 

Drugmakers have been lining up to tout new drug price policies lately, from deferring increases to freezing drug prices. Merck & Co. Inc. went a step further on Thursday, announcing a cap on average increases and cuts to some drug prices. The largest percentage cut announced was a 60% price reduction for its Zepatier treatment for hepatitis C.